Status:

ENROLLING_BY_INVITATION

Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness Registry

Lead Sponsor:

Biomedical Discoveries and Neuroscientific Foundations LLC

Conditions:

Major Depressive Disorder

MDD

Eligibility:

All Genders

12+ years

Brief Summary

The goal of this observational study is to record and analyze factors putatively affecting the clinical outcomes among patients undergoing transcranial magnetic stimulation (TMS) treatment for major d...

Eligibility Criteria

Inclusion

  • Have a primary diagnosis of major depressive disorder (MDD) and/or generalized anxiety disorder (GAD)
  • Are receiving outpatient care,
  • Voluntarily provide competent consent for treatment,
  • Are 12 years of age or older,
  • Are able to adhere to the weekly assessment schedule for primary outcome measures,
  • Have been assessed by their prescribing physician as suitable candidates for TMS treatment in terms of safety and presenting indication,
  • Have consented to undergo a therapeutic course of TMS treatment at one of the participating clinic sites,
  • Are able to communicate in the English language.

Exclusion

  • Have been found to have any contraindication to TMS treatment by their prescribing physician,
  • Are considered unsuitable for outpatient care due to illness severity or other factors in the opinion of their prescribing physician,
  • Have active suicidal intent or plan,
  • Are unable to adhere to or decline participation in the weekly assessment schedule for primary outcome measures,
  • Lack the ability to communicate in the English language.

Key Trial Info

Start Date :

June 27 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2029

Estimated Enrollment :

5000 Patients enrolled

Trial Details

Trial ID

NCT06512324

Start Date

June 27 2024

End Date

December 31 2029

Last Update

July 22 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Kind Health Group

Encinitas, California, United States, 92024

2

Salience Research Institute

Plano, Texas, United States, 75093